REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Avelon Arise Sdn. Bhd. (Malaysia)

Main Activities: Pharmacies and Drug Stores
Full name: Avelon Arise Sdn. Bhd. Profile Updated: August 31, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Avelon Arise Sdn. Bhd. is based in Malaysia, with the head office in Kuala Lumpur. The company operates in the Pharmacies and Drug Stores sector. It was first established on May 26, 2016. From the latest financial highlights, Avelon Arise Sdn. Bhd. reported a net sales revenue drop of 11.48% in 2023. Over the same period, its total assets grew by 10.39%. In 2023, Avelon Arise Sdn. Bhd.’s net profit margin increased by 0.34%.

Headquarters
No. 28, Persiaran Ara Kiri, Lucky Garden, Bangsar
Kuala Lumpur; Federal Territories; Postal Code: 59100

Contact Details: Purchase the Avelon Arise Sdn. Bhd. report to view the information.

Basic Information
Outstanding Shares:
Purchase the Avelon Arise Sdn. Bhd. report to view the information.
Financial Auditors:
Purchase the Avelon Arise Sdn. Bhd. report to view the information.
Incorporation Date:
May 26, 2016
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Avelon Arise Sdn. Bhd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency MYR. Absolute financial data is included in the purchased report.
Net sales revenue
-11.48%▼
Total operating revenue
-11.48%▼
Operating profit (EBIT)
-12.3%▼
EBITDA
-13.52%▼
Net Profit (Loss) for the Period
-6.24%▼
Total assets
10.39%▲
Total equity
12.16%▲
Operating Profit Margin (ROS)
-0.07%▼
Net Profit Margin
0.34%▲
Return on Equity (ROE)
-3.82%▼
Quick Ratio
0.26%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo